Perception in Parkinson's Disease
Launched by BOSTON UNIVERSITY CHARLES RIVER CAMPUS · Jul 29, 2022
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Perception in Parkinson's Disease," is looking into how different visual experiences, including unusual ones like visual hallucinations, relate to important aspects of daily life for people with Parkinson's disease. The study aims to understand how these perceptual experiences connect with factors such as thinking ability, mood, and levels of alertness or sleepiness. It's important to note that you do not need to have visual hallucinations to participate; anyone with Parkinson's can join.
To be eligible for this study, participants must be at least 40 years old, have a self-reported diagnosis of Parkinson's disease, be able to speak English, and have functional vision. You also need access to the internet and a computer or laptop to take part in the research. This study is observational, which means there won't be any treatments or interventions involved; instead, researchers will simply observe and gather information from participants. If you're interested, this is a great opportunity to contribute to our understanding of how perception affects those living with Parkinson's disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must be at least 40 years old
- • Have a self-reported diagnosis of idiopathic PD
- • Be proficient English speakers
- • Have functional vision
- • Have internet access, and access to a desktop computer or laptop
- Exclusion Criteria:
- • Self-reported poor vision (non-functional range)
- • Lack of access to internet and either a desktop computer or laptop
About Boston University Charles River Campus
Boston University Charles River Campus is a prominent academic institution dedicated to advancing health and science through innovative research and education. As a sponsor of clinical trials, the campus leverages its extensive resources and interdisciplinary expertise to facilitate groundbreaking studies that aim to improve patient outcomes and contribute to the understanding of various medical conditions. With a commitment to ethical research practices and collaboration with healthcare professionals, Boston University Charles River Campus plays a vital role in translating scientific discoveries into clinical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Alice Cronin-Golomb, PhD
Principal Investigator
Boston University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials